Hong Kong trials surgical procedure for Alzheimer's disease
Hızlı Bakış
- Hong Kong researchers at CUHK are testing a surgical procedure for Alzheimer's, pioneered in mainland China, which has shown promise in improving patients' daily functions.
- The procedure was banned for unregulated use in mainland China due to safety concerns, prompting CUHK's controlled trials.
Yapay zekâ özeti
Neden Önemli?
A surgical procedure for Alzheimer's, pioneered in mainland China, is being tested in Hong Kong after its unregulated use was banned in China due to safety and effectiveness concerns.
A surgical procedure for Alzheimer’s disease being tested in Hong Kong has the potential to improve patients’ ability to take care of their basic needs such as getting dressed and remaining socially engaged.
The clinical application was pioneered by a mainland Chinese doctor in Hangzhou as early as 2018 and quickly gained nationwide popularity, fuelled by viral social media videos showing dramatic post-surgery transformation of patients.
However, uncertainty about the procedure’s safety and effectiveness led China’s National Health Commission to ban its unregulated use in July 2025, pledging to review it when sufficient evidence was available.
CUHK researchers obtained approval last year and have recruited four patients so far for clinical trials, with one recovering so well that he seemed like a “completely new person … so sharp”, according to his wife.
Dr Tor Chiu, an honorary associate professor of surgery at CUHK, said his research team hoped to verify whether the procedure, performed under strict scientific controls, could improve the condition of Alzheimer’s patients.
He added that the research team was currently recruiting potential patients.
Bundan Sonra Ne Olabilir?
Yapay zekâ öngörüsü — kesinlik taşımaz
China's National Health Commission will review the procedure after sufficient evidence is available.
Çok muhtemel · Aylar içinde
Açık Sorular
- What are the specific risks of the procedure?
- What are the long-term outcomes of the CUHK trials?
- How many patients will be recruited in total?
